Immune-linked flu mutations tied to lower virus levels
An observational study of 75 hospitalized patients aged 41 to 95 linked older age to fewer of these viral mutations, especially above 75.
Edited by Boris Djordjevic · AgingResearch.News
Researchers studied 75 hospitalized patients aged 41 to 95 infected with the H3N2 subtype of influenza A in an observational study. They sequenced viral RNA, the virus's genetic material, in respiratory samples. They examined mutations associated with enzymes that can change viral RNA as part of the body's early antiviral defenses.
More of these mutations were linked to lower amounts of virus. Older age was also linked to fewer mutations, especially in patients older than 75. The link with viral levels held after accounting for age, inflammation and disease severity. The authors suggested that the mutations may indicate an antiviral role for these enzymes. They also suggested that reduced enzyme activity with age may contribute to more severe disease.
Why it matters
Seasonal influenza causes substantial mortality, especially among older people. The study bears on whether age-related differences in early antiviral defenses may contribute to that vulnerability.
Caveats
This observational study could not show that the mutations lowered viral levels or that enzyme activity declined with age. The findings concerned hospitalized patients aged 41 to 95 with one influenza subtype.
From the paper
- Participants
The included 75 influenza patients had a median age of 81.2 years, ranging from 40.9 to 95.4 years (IQR 73.1–86.9 yr).
Quoted word for word from the full text on tandfonline.com.
The paper
University of Gothenburg
Infectious Diseases, Nov 2, 2026, Open access, CC BY-NC-ND
Comments
Be the first to comment.